Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The endogenous decline of plasma GHK begins well before visible aging 1
However, seeing meaningful results may take longer
This triple-action mechanism distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
Da die Konzentration im Alter abnimmt, gilt eine erhhte Zufuhr als verjngend und das Hautbild verfeinernd
US$ 28.06
US$ 22.65
US$ 20.90
US$ 21.65
US$ 21.26
